Patient-centered Mobile Health Intervention to Improve Self-care in Patients With Chronic Heart Failure
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 50 - Any |
| Updated: | 2/7/2019 |
| Start Date: | January 21, 2019 |
| End Date: | December 31, 2019 |
| Contact: | Spyros Kitsiou, PhD |
| Email: | skitsiou@uic.edu |
| Phone: | 312-355-3519 |
iCardia4HF: A Patient-centered Mobile Health Intervention to Promote Self-care and Improve Patient Outcomes in Chronic Heart Failure
Approximately 6.5 million people have heart failure (HF) in the United States, and 960,000
new cases are reported each year. HF is one of the most common hospital diagnosis among older
adults. About 40% of patients are readmitted within 1-year following their first admission
for HF and hospitalization accounts for approximately 80% of the costs of HF management. This
pilot study aims to assess the feasibility, acceptability, and preliminary efficacy of a
patient-centered mobile health (mHealth) technology intervention in older adults with chronic
heart failure.
new cases are reported each year. HF is one of the most common hospital diagnosis among older
adults. About 40% of patients are readmitted within 1-year following their first admission
for HF and hospitalization accounts for approximately 80% of the costs of HF management. This
pilot study aims to assess the feasibility, acceptability, and preliminary efficacy of a
patient-centered mobile health (mHealth) technology intervention in older adults with chronic
heart failure.
This is a single site, two-arm, pilot randomized controlled trial that aims to examine the
feasibility, acceptability and preliminary efficacy of a mobile phone-based intervention
compared to usual care in older adult patients with HF (≥50 years). Forty (n=40) patients
from the University of Illinois Hospital & Health Sciences system will be enrolled in the
study, randomly assigned to the intervention or usual care group, and followed for 60 days.
Patients in the intervention group will receive the Heart Failure Health Storylines mobile
app developed by Self Care Catalysts in collaboration with the Heart Failure Society of
America, three connected health devices from Fitbit and Nokia that interface with the mobile
app, and tailored text-messages targeting health beliefs, self-care efficacy, and knowledge
about HF. The control group will receive standard care which involves patient education and
outpatient follow up with physical and laboratory examinations as needed. The primary study
outcome is change in self-care and quality of life. Secondary outcomes include hospital
re-admissions and emergency room visits.
feasibility, acceptability and preliminary efficacy of a mobile phone-based intervention
compared to usual care in older adult patients with HF (≥50 years). Forty (n=40) patients
from the University of Illinois Hospital & Health Sciences system will be enrolled in the
study, randomly assigned to the intervention or usual care group, and followed for 60 days.
Patients in the intervention group will receive the Heart Failure Health Storylines mobile
app developed by Self Care Catalysts in collaboration with the Heart Failure Society of
America, three connected health devices from Fitbit and Nokia that interface with the mobile
app, and tailored text-messages targeting health beliefs, self-care efficacy, and knowledge
about HF. The control group will receive standard care which involves patient education and
outpatient follow up with physical and laboratory examinations as needed. The primary study
outcome is change in self-care and quality of life. Secondary outcomes include hospital
re-admissions and emergency room visits.
Inclusion Criteria:
- Hospitalized or recently discharged from UI Health (≤30-days) patients with a primary
or secondary diagnosis of HF as defined by the International Classification of
Diseases (ICD-10) codes
- Stage C, NYHA I, II or III
- ≥ 50 years of age
- Own a smartphone with text-messaging and internet plan
- Ability to speak and read English
- Live within 30 miles from UI Health
Exclusion Criteria:
- On an active waiting list for implanted ventricular assist device or heart transplant
- Advanced renal disease (dialysis or creatinine >4.0mg/dL)
- End-stage HF (hospice candidate)
- Active cancer
- Individuals who are not their own primary caregiver
- Discharge to a setting other than home
- Patients with baseline Montreal Cognitive Assessment (MoCA) score of < 22
We found this trial at
1
site
Click here to add this to my saved trials
